PARIS —
Colombian Nairo Quintana has been retrospectively disqualified from this year’s
Tour de France after testing positive for tramadol, the
International Cycling Union (UCI) announced on Wednesday.
اضافة اعلان
Former two-time
runner-up Quintana, 32, finished sixth overall in the race which ended on July
24.
The pain
medication has been banned by the UCI since 2019.
“The UCI
announces that the Colombian rider Nairo Alexander Quintana Rojas has been
sanctioned for an infringement of the in-competition ban on using tramadol as set
out in the UCI Medical Rules with the aim of protecting the safety and health
of riders in light of the side-effects of this substance,” the body said.
“The analyses of
two dried blood samples provided by the rider on July 8 and 13 during the 2022
Tour de France revealed the presence of tramadol and its two main metabolites.
“In accordance
with the UCI Medical Rules, the rider is disqualified from the 2022 Tour de
France. This decision may be appealed before the Court of Arbitration for Sport
within the next 10 days.
“As this is a
first offence, Nairo Alexander Quintana Rojas is not declared ineligible and
can therefore participate in competitions,” it added.
On Tuesday,
Quintana’s Arkea-Samsic team announced he had signed a contract extension until
2025 and has been included in their squad for the Vuelta a Espana which begins
on Friday.
“I consider the
Team Arkea-Samsic to be a family in which I feel at home,” Quintana said.
“I very quickly
became convinced that I still had some great sporting challenges to take up
under the Arkea-Samsic jersey and that our beautiful common history initiated
since 2020 could only continue,” he added.
Quintana won the
Giro d’Italia in 2014 and the Vuelta two years later.
Read more Sports
Jordan News
.jpg)
.jpg)
